InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Dulac Edward J III, Chief Financial Officer. Director active across 1 company, notably Fate Therapeutics INC. Aggregated, 12 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €409k. Activity tracked since 19 August 2021. The latest transaction was disclosed on 25 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations12 total
33,302 shares0Common StockSEC:0000899243-22-003443:0
33,302 shares0Common StockSEC:0000899243-22-003443
1,380 shares@ US$48.250.029% mcap4.9% of flowCommon StockSEC:0001209191-22-003168
1,380 shares@ US$48.250.029% mcap2.5% of flowCommon StockSEC:0001209191-22-003168:0
14,437 shares@ US$35.520.22% mcap38.4% of flowCommon StockSEC:0001209191-21-070768
14,437 shares@ US$35.520.22% mcap19.2% of flowCommon StockSEC:0001209191-21-070768:0
59,540 shares0Common StockSEC:0001209191-21-066159:0
59,540 shares0Common StockSEC:0001209191-21-066159
17,325 shares@ US$35.520.26% mcap22.2% of flowCommon StockSEC:0001209191-21-058176:0
17,325 shares@ US$35.520.26% mcap44.4% of flowCommon StockSEC:0001209191-21-058176
1,937 shares@ US$87.900.071% mcap12.3% of flowCommon StockSEC:0001209191-21-052742
1,937 shares@ US$87.900.071% mcap6.1% of flowCommon StockSEC:0001209191-21-052742:0
12 of 12 declarations
About Dulac Edward J III
Edward J. Dulac III is the Chief Financial Officer at Fate Therapeutics Inc. As Chief Financial Officer, he is responsible for the company's financial management, including financial planning and analysis. His role is essential to ensure Fate Therapeutics' financial health.
